Burden of non-serious infections during biological use for rheumatoid arthritis.

ABSTRACT:

Introduction

Biologicals have become a cornerstone in rheumatoid arthritis (RA) treatment. The increased risk of serious infections associated with their use is well-established. Non-serious infections, however, occur more frequently and are associated with a high socioeconomic burden and impact on quality of life but have not received the same attention in the literature to date. The aim of this study was to gain insight into the various non-serious infections reported in RA patients using biologicals and their experienced burden.

Materials and methods

The Dutch Biologic Monitor was a prospective observational study that included adults with rheumatoid arthritis and biological use who answered bimonthly questionnaires on the adverse drug reactions (ADRs) they experienced fr

SUBMITTER: Bergmans B 

PROVIDER: S-EPMC10878515 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature